Verastem (VSTM) Assets Average (2012 - 2026)
Verastem (VSTM) recorded quarterly Assets Average of $237.1 million in Q1 2026, up 12.04% quarter-over-quarter from $211.6 million in Q4 2025, and up 103.33% on a YoY basis from $116.6 million in Q1 2025.
Verastem (VSTM) Assets Average (2012 - 2026) Analysis & Trends
Verastem's Assets Average history runs 15 years deep, the most recent figure standing at $237.1 million for Q1 2026.
- In Q1 2026, Assets Average rose 103.33% year-over-year to $237.1 million; the TTM figure through Mar 2026 stood at $237.1 million (up 103.33% YoY), while the FY2025 annual figure was $174.0 million, up 38.5% from the prior year.
- Assets Average was $237.1 million for Q1 2026 at Verastem, up from $211.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $237.1 million in Q1 2026 to a low of $103.1 million in Q4 2022.
- Historically, Assets Average has averaged $143.4 million across 5 years, with a median of $116.6 million in 2025.
- The sharpest annual moves came in 2024 and 2026: Assets Average tumbled 36.91% in 2024, then surged 103.33% in 2026.
- A 5-year view of Assets Average shows it stood at $103.1 million in 2022, then jumped by 58.08% to $162.9 million in 2023, then sank by 30.06% to $114.0 million in 2024, then jumped by 85.72% to $211.6 million in 2025, then rose by 12.04% to $237.1 million in 2026.
- The last three Assets Average figures came in at $237.1 million (Q1 2026), $211.6 million (Q4 2025), and $186.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 237.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.13 Mn |
| Dec 31, 2025 | 211.65 Mn |
| Sep 30, 2025 | 186.56 Mn |
| Jun 30, 2025 | 163.98 Mn |
| Mar 31, 2025 | 116.62 Mn |
| Dec 31, 2024 | 113.96 Mn |
| Sep 30, 2024 | 116.06 Mn |
| Jun 30, 2024 | 114.64 Mn |
| Mar 31, 2024 | 136.63 Mn |
| Dec 31, 2023 | 162.94 Mn |
| Sep 30, 2023 | 183.96 Mn |
| Jun 30, 2023 | 156.32 Mn |
| Mar 31, 2023 | 107.96 Mn |
| Dec 31, 2022 | 103.07 Mn |
| Sep 30, 2022 | 105.75 Mn |
| Jun 30, 2022 | 108.28 Mn |
| Mar 31, 2022 | 112.41 Mn |
| Dec 31, 2021 | 110.27 Mn |
| Sep 30, 2021 | 117.88 Mn |
| Jun 30, 2021 | 130.40 Mn |